Becton Dickinson and Co (NYSE:BDX) has received a consensus recommendation of “Hold” from the fifteen analysts that are currently covering the stock. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $176.68.
A number of analysts recently commented on BDX shares. Zacks Investment Research upgraded shares of Becton Dickinson and from a “hold” rating to a “buy” rating and set a $189.00 target price on the stock in a report on Friday, November 25th. Royal Bank of Canada reiterated a “hold” rating and issued a $177.00 target price on shares of Becton Dickinson and in a report on Friday, January 6th. Raymond James Financial, Inc. reiterated an “outperform” rating and issued a $180.00 target price (down from $200.00) on shares of Becton Dickinson and in a report on Thursday, January 5th. Leerink Swann reiterated a “market perform” rating and issued a $185.00 target price (up from $180.00) on shares of Becton Dickinson and in a report on Monday, November 21st. Finally, JPMorgan Chase & Co. downgraded shares of Becton Dickinson and from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $190.00 to $175.00 in a report on Tuesday, January 3rd.
Your IP Address:
In other Becton Dickinson and news, VP Jeffrey S. Sherman sold 31,464 shares of the company’s stock in a transaction that occurred on Wednesday, February 15th. The shares were sold at an average price of $180.02, for a total value of $5,664,149.28. Following the transaction, the vice president now owns 22,094 shares in the company, valued at approximately $3,977,361.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.40% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Garde Capital Inc. bought a new position in Becton Dickinson and during the third quarter valued at $690,000. Advisory Services Network LLC raised its position in Becton Dickinson and by 4.2% in the third quarter. Advisory Services Network LLC now owns 5,803 shares of the company’s stock valued at $1,043,000 after buying an additional 236 shares in the last quarter. Catawba Capital Management VA raised its position in Becton Dickinson and by 0.4% in the third quarter. Catawba Capital Management VA now owns 44,282 shares of the company’s stock valued at $7,959,000 after buying an additional 190 shares in the last quarter. Burns J W & Co. Inc. NY raised its position in Becton Dickinson and by 7.4% in the third quarter. Burns J W & Co. Inc. NY now owns 18,255 shares of the company’s stock valued at $3,281,000 after buying an additional 1,258 shares in the last quarter. Finally, West Oak Capital LLC raised its position in Becton Dickinson and by 6,250.0% in the third quarter. West Oak Capital LLC now owns 2,921 shares of the company’s stock valued at $525,000 after buying an additional 2,875 shares in the last quarter. Hedge funds and other institutional investors own 82.30% of the company’s stock.
Becton Dickinson and (NYSE:BDX) opened at 182.63 on Thursday. The firm has a market cap of $38.87 billion, a price-to-earnings ratio of 30.40 and a beta of 1.00. Becton Dickinson and has a 12-month low of $146.57 and a 12-month high of $186.11. The company’s 50 day moving average is $181.27 and its 200 day moving average is $174.11.
Becton Dickinson and (NYSE:BDX) last released its earnings results on Thursday, February 2nd. The company reported $2.33 EPS for the quarter, topping analysts’ consensus estimates of $2.12 by $0.21. Becton Dickinson and had a net margin of 10.54% and a return on equity of 25.25%. The business had revenue of $2.92 billion for the quarter, compared to the consensus estimate of $2.86 billion. During the same period in the previous year, the firm earned $1.96 EPS. The business’s revenue for the quarter was down 2.1% on a year-over-year basis. On average, equities analysts anticipate that Becton Dickinson and will post $9.43 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 31st. Stockholders of record on Friday, March 10th will be issued a dividend of $0.73 per share. The ex-dividend date of this dividend is Wednesday, March 8th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.60%. Becton Dickinson and’s dividend payout ratio is currently 48.42%.
Becton Dickinson and Company Profile
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
Receive News & Ratings for Becton Dickinson and Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co and related companies with MarketBeat.com's FREE daily email newsletter.